Fulcrum Therapeutics Inc (FULC)

SG&A Expenses

$7.46M

Quarterly · Period ending: · USD

FULC logo

FULC SG&A Expenses

Latest reported$7.46M
FULC Quarterly SG&A Expenses ($1.74M → $7.46M)
High-resolution chart · PNG

FULC sg&a expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Fulcrum Therapeutics Inc SG&A Expenses — Quarterly (USD)
Period endingSG&A Expenses (USD)
7,462,000
8,102,000
7,277,000
7,562,000
6,828,000
6,999,000
7,716,000
8,424,000
10,247,000
10,061,000
9,356,000
9,961,000
10,323,000
11,520,000
10,130,000
9,707,000
11,098,000
10,759,000
9,705,000
8,628,000
6,685,000
5,498,000
5,867,000
5,312,000
5,149,000
5,064,000
4,403,000
3,510,000
2,634,000
2,598,000
2,391,000
2,125,000
2,061,000
1,737,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.